Investigating the Promise of Anellovectors to Address Tropism, Immunogenicity & Redosing in Gene Therapy
Time: 5:45 pm
day: Day One
Details:
- Sequencing of human anelloviruses reveals a vast genetic diversity with potential implications for gene therapy, such as:
- Generating more targeted gene delivery vectors
- Enabling re-dosing and improving the therapeutic index of gene therapies
- An update will be provided on Ring Therapeutics’ efforts in developing Anellovectors
